A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

被引：0
作者：
E. Esteban
González de Sande
J. Puertas
J. Fra
I. Palacio
J.M. Vieitez
J.L. Fernández
I. Muñiz
A. Modollel
J. Carrasco
M. Sala
A.J. Lacave
机构：
来源：
Breast Cancer Research and Treatment | 2000年 / 62卷
关键词：
advanced breast cancer; vinorelbine; epirubicin; cyclophosphamide; combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background.Vinorelbine (Navelbin®; N) has proven to be active in patients with advanced breast cancer (ABC) and cyclophosphamide (C) and epirubicin (Epiadriamycin®: E) are still among the main cytostatic agents against this tumor. On this basis was carried out a study to determine the activity and toxicity of the combination of these three agents (CEN).
引用
收藏
页码：127 / 133
页数：6
相关论文
共 50 条
[41]   Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer [J].
J Bonneterre ;
V Dieras ;
M Tubiana-Hulin ;
P Bougnoux ;
M-E Bonneterre ;
T Delozier ;
F Mayer ;
S Culine ;
N Dohoulou ;
B Bendahmane .
British Journal of Cancer, 2004, 91 :1466-1471
[42]   Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer [J].
Recchia, F ;
De Filippis, S ;
Rosselli, M ;
Saggio, G ;
Pompili, P ;
Piccinini, M ;
Rea, S .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (04) :392-396
[43]   Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil [J].
David Jamieson ;
Jo Lee ;
Nicola Cresti ;
Rosanna Jackson ;
Melanie Griffin ;
Julieanne Sludden ;
Mark Verrill ;
Alan V. Boddy .
Cancer Chemotherapy and Pharmacology, 2014, 74 :667-674
[44]   Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil [J].
Jamieson, David ;
Lee, Jo ;
Cresti, Nicola ;
Jackson, Rosanna ;
Griffin, Melanie ;
Sludden, Julieanne ;
Verrill, Mark ;
Boddy, Alan V. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) :667-674
[45]   Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor:: A high-activity, dose-dense weekly regimen for advanced breast cancer [J].
Nisticò, C ;
Garufi, C ;
Barni, S ;
Frontini, L ;
Gallà, DAP ;
Giannarelli, D ;
Vaccaro, A ;
D'Ottavio, AM ;
Terzoli, E .
ANNALS OF ONCOLOGY, 1999, 10 (08) :937-942
[46]   First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study [J].
Pectasides, D ;
Dimopoulos, MA ;
Aravantinos, G ;
Kalophonos, HP ;
Papacostas, P ;
Briasoulis, E ;
Cogas, E ;
Papadimitriou, C ;
Skarlos, D ;
Kosmidis, P ;
Fountzilas, G .
ANTICANCER RESEARCH, 2001, 21 (05) :3575-3580
[47]   Docetaxel and epirubicin in advanced breast cancer [J].
Sessa, C ;
Pagani, O .
ONCOLOGIST, 2001, 6 :13-16
[48]   Docetaxel Plus Vinorelbine as Salvage Chemotherapy in Advanced Breast Cancer: A Phase II Study [J].
Javier Rodríguez ;
Emiliano Calvo ;
J. Cortes ;
Marta Santisteban ;
J. Perez-Calvo ;
Rafael Martínez-Monge ;
Antonio Brugarolas ;
Óscar Fernández-Hidalgo .
Breast Cancer Research and Treatment, 2002, 76 :47-56
[49]   Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer:: A phase II study [J].
Rodríguez, J ;
Calvo, E ;
Cortes, J ;
Santisteban, M ;
Perez-Calvo, J ;
Martínez-Monge, R ;
Brugarolas, A ;
Fernández-Hidalgo, O .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :47-56
[50]   Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study [J].
Liu, Chien-Ting ;
Hsieh, Meng-Che ;
Su, Yu-Li ;
Hung, Chaio-Ming ;
Pei, Sung-Nan ;
Liao, Chun-Kai ;
Tsa, Yu-Fen ;
Liao, Hsiu-Yun ;
Liu, Wei-Ching ;
Chi, Chong-Chi ;
Wu, Shih-Chung ;
Wang, Shih-Ho ;
Wei, Ching-Ting ;
Rau, Kun-Ming .
JOURNAL OF CANCER, 2021, 12 (17) :5355-5364
12345